Ambar Protein Industries Ltd (519471) — FY26 Annual Report | 31 August 2026 (2 announcements)

Ambar Protein Industries Ltd reported a 18.7% revenue increase to ₹50,065.59 lakhs for FY2025-26, but profit after tax declined 27.2% to [amount context mismatch] lakhs due to margin pressure. The Board recommended no dividend, citing resource conservation. Key highlights include ₹575 crore equity capital, ₹704.37 crore total comprehensive income, and ₹1,832.54 crore total assets. The company maintained its edible oil manufacturing focus with no new business diversification. Governance disclosures confirm compliance with SEBI Listing Regulations, and the 33rd AGM will be held on 30th September 2026 to transact ordinary and special business including director appointments, remuneration variations, and related party transaction approvals.

Ambar Protein Industries Ltd confirmed compliance with SEBI Regulation 36(1)(b) by sending a letter to shareholders who haven't registered email addresses, directing them to access the FY2025-26 Integrated Annual Report via its website. The letter also reminded shareholders to update KYC details, including PAN, address, mobile number, bank account, and nomination, and to dematerialize physical securities by April 1, 2024, as mandated by SEBI.